Latest filing published 16 Nov 2023 for Enfusion, Inc., €47k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dan Groman: trading record in brief
Dan Groman is a declared insider of Enfusion, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 40 filings, for trades running from 15 June 2022 to 14 November 2023.
Every open-market trade on record is a sale: 18 sales worth €1.1M. Outside the open market, there are 22 share grants. In 2023 alone, the filings show no purchases and 16 sales.
On 16 November 2023 came the latest disclosure, an open-market sale for €47k in Enfusion, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dan Groman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$9.975.0% of flowClass A Common StockSEC:0001104659-23-119218:0
- 5,000 shares@ US$9.094.6% of flowClass A Common StockSEC:0001104659-23-110116:0
- 5,000 shares@ US$9.074.8% of flowClass A Common StockSEC:0001104659-23-102823:0
- 31,444 shares0Class A Common StockSEC:0001104659-23-093501:0
- 4,045 shares0Class A Common StockSEC:0001104659-23-092110:0
- 4,451 shares0Class A Common StockSEC:0001104659-23-091493:0
- 4,855 shares0Class A Common StockSEC:0001104659-23-090487:0
- 5,259 shares0Class A Common StockSEC:0001104659-23-089939:0
- 3,877 shares@ US$11.314.2% of flowClass A Common StockSEC:0001104659-23-082347:0
- 3,877 shares@ US$8.863.4% of flowClass A Common StockSEC:0001104659-23-073760:0
- 44,260 shares0Class A Common StockSEC:0001104659-23-072915:0
- 113,538 shares0Class A Common StockSEC:0001104659-23-065468:0
- 3,877 shares@ US$8.003.1% of flowClass A Common StockSEC:0001104659-23-064130:0
- 15,048 shares@ US$8.3412.3% of flowClass A Common StockSEC:0001104659-23-059756:0
- 21,974 shares0Class A Common StockSEC:0001104659-23-051361:0
- 3,877 shares@ US$9.663.7% of flowClass A Common StockSEC:0001104659-23-047201:0
- 3,877 shares@ US$10.944.3% of flowClass A Common StockSEC:0001104659-23-035072:0
- 3,877 shares@ US$10.934.3% of flowClass A Common StockSEC:0001104659-23-024311:0
- 21,976 shares0Class A Common StockSEC:0001104659-23-007629:0
- 3,877 shares@ US$10.934.2% of flowClass A Common StockSEC:0001104659-23-005055:0
- 32,190 shares@ US$11.2636.4% of flowClass A Common StockSEC:0001104659-23-003402:0
- 5,651 shares0Class A Common StockSEC:0001104659-23-002349:0
- 7,000 shares@ US$13.6910.0% of flowClass A Common StockSEC:0001104659-22-119547:0
- 21,976 shares0Class A Common StockSEC:0001104659-22-112117:0
- 6,339 shares0Class A Common StockSEC:0001104659-22-072533:0
25 of 25 declarations